Table 1.
Clinicopathological variables | Cohort I | Cohort II | |||||||
---|---|---|---|---|---|---|---|---|---|
n | Notch1 expression | aP value | n | Notch1 expression | aP value | ||||
Low (n = 75) | High (n = 75) | Low (n = 36) | High (n = 31) | ||||||
Sex | Male | 122 | 61 | 61 | 1.000 | 54 | 31 | 23 | 0.219 |
Female | 28 | 14 | 14 | 13 | 5 | 8 | |||
Age, years | ≤ 50 | 63 | 35 | 28 | 0.247 | 38 | 17 | 21 | 0.091 |
> 50 | 87 | 40 | 47 | 29 | 19 | 10 | |||
Serum AFP, ng/mL | ≤ 20 | 63 | 33 | 30 | 0.620 | 23 | 12 | 11 | 0.853 |
> 20 | 87 | 42 | 45 | 44 | 24 | 20 | |||
Tumor nodule number | Solitary | 123 | 60 | 63 | 0.524 | 52 | 28 | 24 | 0.972 |
Multiple | 27 | 15 | 12 | 15 | 8 | 7 | |||
Maximal tumor size, cm | ≤ 5 | 69 | 35 | 34 | 0.870 | 37 | 21 | 16 | 0.581 |
> 5 | 81 | 40 | 41 | 30 | 15 | 15 | |||
Microvascular invasion | Absent | 68 | 40 | 28 | 0.049 | 39 | 24 | 15 | 0.130 |
Present | 82 | 35 | 47 | 28 | 12 | 16 | |||
Tumor differentiation | Well | 19 | 9 | 10 | 0.806 | 22 | 14 | 8 | 0.256 |
Moderately or poorly | 131 | 66 | 65 | 45 | 22 | 23 | |||
TNM stage | I and II | 97 | 49 | 48 | 0.864 | 47 | 26 | 21 | 0.689 |
III and IV | 53 | 26 | 27 | 20 | 10 | 10 |
a Pearson chi-square test was used for comparison between subgroups. Significant results (P < 0.05) are given in bold